Lipid control in patients with coronary heart disease treated in primary care or cardiology clinics

David Pereg*, Avishay Elis, Yoram Neuman, Morris Mosseri, Avi Leader, David Segev, Martine Granek-Catarivas, Michael Lishner, Doron Hermoni

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background Guidelines recommend low-density lipoprotein-cholesterol (LDL-C) target of <70 mg/dL in patients with coronary disease. However, this goal is not achieved in many patients. Objectives We compared LDL-C control in patients with coronary disease treated by a primary care physician or with the addition of a cardiologist. Methods Included were patients with coronary disease who had full lipid profile. Primary end points included the percentage of patients who achieved the LDL-C goals of <100 mg/dL and <70 mg/dL. Results Of the 27,172 patients, 12,965 (47.7%) were followed only by a primary care physician and 14,207 (52.3%) were also followed by a cardiologist. Overall, 18,366 patients (67.6%) achieved the LDL-C goal of <100 mg/dL, and 6517 patients (24%) achieved the LDL-C goal of <70 mg/dL. Patients followed by a cardiologist more frequently achieved the LDL-C goal of <100 mg/dL (74.3% and 60.3%; P <.0001, in patients treated by a cardiologist or by a primary care physician, respectively), as well as the lower LDL-C goal of <70 mg/dL (27.2% and 20.4%; P <.0001, in patients treated by a cardiologist or by a primary care physician, respectively). Differences in LDL-C control remained significant after a multivariate adjustment. Patients followed by a cardiologist were more commonly treated with highly potent statins and with non-statin cholesterol-lowering drugs. Conclusions Among patients with coronary disease, those followed by a cardiologist receive a more aggressive antilipid treatment and more frequently achieve lipids goals. Nevertheless, the disappointingly poor lipid control in both groups warrants an effort to improve adherence for guidelines in both primary care and cardiology clinics.

Original languageEnglish
Pages (from-to)637-641
Number of pages5
JournalJournal of Clinical Lipidology
Volume7
Issue number6
DOIs
StatePublished - Nov 2013

Keywords

  • Cholesterol
  • Coronary disease
  • Guideline adherence
  • HMG-CoA reductase inhibitors
  • Primary health care
  • Secondary prevention

Fingerprint

Dive into the research topics of 'Lipid control in patients with coronary heart disease treated in primary care or cardiology clinics'. Together they form a unique fingerprint.

Cite this